127 related articles for article (PubMed ID: 37003035)
1. Physalis alkekengi L. var. franchetii combined with hormone therapy for atopic dermatitis.
Yang M; Zhao M; Xia T; Chen Y; Li W; Zhang H; Peng M; Li C; Cao X; Liang L; Yue Y; Zhong L; Du J; Li J; Wang Y; Shu Z
Biomed Pharmacother; 2023 Jun; 162():114622. PubMed ID: 37003035
[TBL] [Abstract][Full Text] [Related]
2. Physalis alkekengi L. var. franchetii (Mast.) Makino: An ethnomedical, phytochemical and pharmacological review.
Li AL; Chen BJ; Li GH; Zhou MX; Li YR; Ren DM; Lou HX; Wang XN; Shen T
J Ethnopharmacol; 2018 Jan; 210():260-274. PubMed ID: 28838654
[TBL] [Abstract][Full Text] [Related]
3. Anti-ulcer and anti-Helicobacter pylori potentials of the ethyl acetate fraction of Physalis alkekengi L. var. franchetii (Solanaceae) in rodent.
Wang Y; Wang SL; Zhang JY; Song XN; Zhang ZY; Li JF; Li S
J Ethnopharmacol; 2018 Jan; 211():197-206. PubMed ID: 28964871
[TBL] [Abstract][Full Text] [Related]
4. Natural Products from
Yang J; Sun Y; Cao F; Yang B; Kuang H
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163960
[TBL] [Abstract][Full Text] [Related]
5. Systems pharmacology reveals the mechanism of activity of Physalis alkekengi L. var. franchetii against lipopolysaccharide-induced acute lung injury.
Yang Y; Ding Z; Wang Y; Zhong R; Feng Y; Xia T; Xie Y; Yang B; Sun X; Shu Z
J Cell Mol Med; 2020 May; 24(9):5039-5056. PubMed ID: 32220053
[TBL] [Abstract][Full Text] [Related]
6. Research on the Chemical Constituents against Alzheimer's Disease of the Fruits of Physalis alkekengi L. var. franchetii (Mast.) Makino.
Teng Y; Yuan Q; Wu Y; Wu S; Su J; Zhang P; Zhang Y
Chem Biodivers; 2023 Sep; 20(9):e202301075. PubMed ID: 37505462
[TBL] [Abstract][Full Text] [Related]
7. Physalis alkekengi L. var. franchetii (Mast.) Makino: A review of the pharmacognosy, chemical constituents, pharmacological effects, quality control, and applications.
Liang L; Li C; Wang Y; Yue Y; Zhang H; Yang M; Cao X; Zhao M; Du J; Peng M; Chen Y; Li W; Xia T; Zhong R; Shu Z
Phytomedicine; 2022 Oct; 105():154328. PubMed ID: 35908519
[TBL] [Abstract][Full Text] [Related]
8. Chemical components and against alzheimer's disease effects of the calyxes of Physalis alkekengi L. var. franchetii (Mast.) Makino.
Teng Y; Gao J; Tan T; Zhang X; Wang Y; Zhang J; Ni L
J Chem Neuroanat; 2024 Mar; 136():102390. PubMed ID: 38228242
[TBL] [Abstract][Full Text] [Related]
9. Research progress on the chemical components and pharmacological effects of
Liu Y; Wang X; Li C; Yu D; Tian B; Li W; Sun Z
Heliyon; 2023 Dec; 9(12):e20030. PubMed ID: 38125457
[No Abstract] [Full Text] [Related]
10. Two new physalins from
Sun JM; He JX; Huang M; Hu HX; Xu LT; Fang KL; Wang XN; Shen T
Nat Prod Res; 2022 Oct; 36(20):5206-5212. PubMed ID: 34180325
[TBL] [Abstract][Full Text] [Related]
11. Non-targeted chromatographic analyses of cuticular wax flavonoids from Physalis alkekengi L.
Kranjc E; Albreht A; Vovk I; Makuc D; Plavec J
J Chromatogr A; 2016 Mar; 1437():95-106. PubMed ID: 26875116
[TBL] [Abstract][Full Text] [Related]
12. Two new physalin derivatives from
Sun JL; Jiang YJ; Cheng L
Nat Prod Res; 2021 Jan; 35(2):203-206. PubMed ID: 31140313
[TBL] [Abstract][Full Text] [Related]
13. Two new sesquiterpenoid glycoside compounds from the calyces of
Teng Y; Zhang XR; Li XL; Gao J; Ni L; Zhan GQ
J Asian Nat Prod Res; 2024 Mar; ():1-8. PubMed ID: 38515328
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of proteins in the extracts of Physalis alkekengi L. var. franchetii (Mast.) Makino using nanoflow reversed-phase liquid chromatography-tandem mass spectrometry].
Yu H; Yan J; Guo M; Jin Y
Se Pu; 2013 Apr; 31(4):362-6. PubMed ID: 23898636
[TBL] [Abstract][Full Text] [Related]
15.
Fu Y; Zhu F; Ma Z; Lv B; Wang X; Dai C; Ma X; Liu P; Lv H; Chen X; Chen Z; Shen L
Onco Targets Ther; 2021; 14():301-314. PubMed ID: 33469308
[TBL] [Abstract][Full Text] [Related]
16. Discovery of physalin biosynthesis and structure modification of physalins in
Qu L; Gan C; Cheng X; Lin C; Wang Y; Wang L; Huang J; Wang J
Front Plant Sci; 2022; 13():956083. PubMed ID: 36299788
[TBL] [Abstract][Full Text] [Related]
17. The ethyl acetate fraction from Physalis alkekengi inhibits LPS-induced pro-inflammatory mediators in BV2 cells and inflammatory pain in mice.
Moniruzzaman M; Bose S; Kim YM; Chin YW; Cho J
J Ethnopharmacol; 2016 Apr; 181():26-36. PubMed ID: 26806571
[TBL] [Abstract][Full Text] [Related]
18. The alleviative effect of flavonol-type Nrf2 activator rhamnazin from Physalis alkekengi L. var. franchetii (Mast.) Makino on pulmonary disorders.
Wu XY; Wang T; Hu HX; Zhang K; Zhao Y; Zhao BB; Lou HX; Wang XN; Shen T
Phytother Res; 2022 Apr; 36(4):1692-1707. PubMed ID: 35129872
[TBL] [Abstract][Full Text] [Related]
19. Identification of absorbed constituents and in vivo metabolites in rats after oral administration of Physalis alkekengi var. franchetii by ultra-high-pressure liquid chromatography quadrupole time-of-flight mass spectrometry.
Feng X; Huo X; Liu H; Chai L; Ding L; Qiu F
Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29055030
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of cytotoxic withanolides from the calyx of Physalis alkekengi L. var franchetii.
Sun Y; Guo T; Zhang FB; Wang YN; Liu Z; Guo S; Li L
Bioorg Chem; 2020 Mar; 96():103614. PubMed ID: 32007725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
